RU2018107052A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2018107052A3 RU2018107052A3 RU2018107052A RU2018107052A RU2018107052A3 RU 2018107052 A3 RU2018107052 A3 RU 2018107052A3 RU 2018107052 A RU2018107052 A RU 2018107052A RU 2018107052 A RU2018107052 A RU 2018107052A RU 2018107052 A3 RU2018107052 A3 RU 2018107052A3
- Authority
- RU
- Russia
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/88—Post-polymerisation treatment
- C08G63/90—Purification; Drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/66—Polyesters containing oxygen in the form of ether groups
- C08G63/664—Polyesters containing oxygen in the form of ether groups derived from hydroxy carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/78—Preparation processes
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/78—Preparation processes
- C08G63/82—Preparation processes characterised by the catalyst used
- C08G63/823—Preparation processes characterised by the catalyst used for the preparation of polylactones or polylactides
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/78—Preparation processes
- C08G63/82—Preparation processes characterised by the catalyst used
- C08G63/85—Germanium, tin, lead, arsenic, antimony, bismuth, titanium, zirconium, hafnium, vanadium, niobium, tantalum, or compounds thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20150106626 | 2015-07-28 | ||
| KR10-2015-0106626 | 2015-07-28 | ||
| PCT/KR2016/008265 WO2017018816A1 (en) | 2015-07-28 | 2016-07-28 | Pharmaceutical composition with improved storage stability and method for preparing the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2018107052A RU2018107052A (ru) | 2019-08-28 |
| RU2018107052A3 true RU2018107052A3 (ja) | 2019-08-28 |
Family
ID=57884841
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2018107052A RU2018107052A (ru) | 2015-07-28 | 2016-07-28 | Фармацевтическая композиция с улучшенной устойчивостью при хранении и способ ее получения |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP3328434A4 (ja) |
| JP (1) | JP6605706B2 (ja) |
| KR (1) | KR101748191B1 (ja) |
| CN (2) | CN106559983A (ja) |
| AU (1) | AU2016299544A1 (ja) |
| BR (1) | BR112018001736A2 (ja) |
| CA (1) | CA2993920A1 (ja) |
| HK (1) | HK1249439A1 (ja) |
| IL (1) | IL257185A (ja) |
| MX (1) | MX2018001219A (ja) |
| RU (1) | RU2018107052A (ja) |
| WO (1) | WO2017018816A1 (ja) |
| ZA (1) | ZA201801189B (ja) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113424057B (zh) * | 2019-04-19 | 2024-04-05 | 海正生物制药有限公司 | 组合物中泊洛沙姆188的检测方法 |
| KR20220082975A (ko) * | 2020-12-10 | 2022-06-20 | 주식회사 삼양홀딩스 | 재건 시간을 단축할 수 있는 고분자 미셀 나노입자의 제조 방법 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR0180334B1 (ko) | 1995-09-21 | 1999-03-20 | 김윤 | 블럭 공중합체 미셀을 이용한 약물전달체 및 이에 약물을 봉입하는 방법 |
| KR100360827B1 (ko) * | 1999-08-14 | 2002-11-18 | 주식회사 삼양사 | 난용성 약물을 가용화하기 위한 고분자 조성물 및 그의 제조방법 |
| EP1280557B1 (en) * | 2000-05-12 | 2012-06-20 | Samyang Corporation | Method for the preparation of polymeric micelle via phase separation of block copolymer |
| US7217770B2 (en) * | 2000-05-17 | 2007-05-15 | Samyang Corporation | Stable polymeric micelle-type drug composition and method for the preparation thereof |
| NZ532198A (en) * | 2001-10-18 | 2006-03-31 | Samyang Corp | Polymeric micelle composition of an amphiphilic block copolymer and a polylactic acid derivative |
| KR101024742B1 (ko) * | 2007-12-31 | 2011-03-24 | 주식회사 삼양사 | 탁산 함유 양친성 블록 공중합체 미셀 조성물 및 그 제조방법 |
| US9801818B2 (en) * | 2007-12-31 | 2017-10-31 | Samyang Biopharmaceuticals Corporation | Method for stabilizing amphiphilic block copolymer micelle composition containing poorly water-soluble drug |
| RU2459840C2 (ru) | 2007-12-31 | 2012-08-27 | Самъянг Корпорейшн | АМФИФИЛЬНЫЙ СОПОЛИМЕР ВЫСОКОЙ ЧИСТОТЫ, СОДЕРЖАЩИЙ ГИДРОФОБНЫЙ БЛОК ИЗ α-ГИДРОКСИКИСЛОТЫ, И СПОСОБ ЕГО ПОЛУЧЕНИЯ |
| EP2201935B1 (en) * | 2008-12-26 | 2020-07-08 | Samyang Biopharmaceuticals Corporation | Polymeric micelle composition containing a poorly soluble drug and preparation method of the same |
| CN101444510B (zh) | 2008-12-31 | 2011-03-09 | 南京卡文迪许生物工程技术有限公司 | 含有伏立康唑的药物制剂及其制备方法 |
| CN104758256B (zh) * | 2014-02-14 | 2016-05-04 | 苏州海特比奥生物技术有限公司 | 一种多西他赛纳米聚合物胶束冻干制剂及其制备方法 |
-
2016
- 2016-07-27 KR KR1020160095413A patent/KR101748191B1/ko active IP Right Grant
- 2016-07-28 MX MX2018001219A patent/MX2018001219A/es unknown
- 2016-07-28 CN CN201680001936.3A patent/CN106559983A/zh active Pending
- 2016-07-28 AU AU2016299544A patent/AU2016299544A1/en not_active Abandoned
- 2016-07-28 CN CN202010292397.1A patent/CN111574702A/zh active Pending
- 2016-07-28 RU RU2018107052A patent/RU2018107052A/ru unknown
- 2016-07-28 JP JP2018504184A patent/JP6605706B2/ja active Active
- 2016-07-28 WO PCT/KR2016/008265 patent/WO2017018816A1/en active Application Filing
- 2016-07-28 BR BR112018001736A patent/BR112018001736A2/pt not_active Application Discontinuation
- 2016-07-28 CA CA2993920A patent/CA2993920A1/en not_active Abandoned
- 2016-07-28 EP EP16830849.2A patent/EP3328434A4/en not_active Withdrawn
-
2018
- 2018-01-28 IL IL257185A patent/IL257185A/en unknown
- 2018-02-21 ZA ZA2018/01189A patent/ZA201801189B/en unknown
- 2018-07-13 HK HK18109124.0A patent/HK1249439A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2018107052A (ru) | 2019-08-28 |
| HK1249439A1 (zh) | 2018-11-02 |
| BR112018001736A2 (pt) | 2018-09-11 |
| KR20170015198A (ko) | 2017-02-08 |
| EP3328434A4 (en) | 2019-03-13 |
| CN106559983A (zh) | 2017-04-05 |
| MX2018001219A (es) | 2018-04-24 |
| IL257185A (en) | 2018-03-29 |
| JP6605706B2 (ja) | 2019-11-13 |
| KR101748191B1 (ko) | 2017-06-19 |
| AU2016299544A1 (en) | 2018-03-08 |
| EP3328434A1 (en) | 2018-06-06 |
| JP2018521094A (ja) | 2018-08-02 |
| WO2017018816A1 (en) | 2017-02-02 |
| CA2993920A1 (en) | 2017-02-02 |
| CN111574702A (zh) | 2020-08-25 |
| ZA201801189B (en) | 2019-01-30 |